These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 19751376

  • 41. [Efficacy of percutaneous caffeine in the treatment of apnea in the premature infant].
    Morisot C, Simoens C, Trublin F, Lhermitte M, Gremillet C, Robert MH, Lequien P.
    Arch Fr Pediatr; 1990 Mar; 47(3):221-4. PubMed ID: 2344252
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Caffeine for apnea of prematurity.
    Coulter DM.
    N Engl J Med; 2006 Aug 31; 355(9):958-9; author reply 959-60. PubMed ID: 16943412
    [No Abstract] [Full Text] [Related]

  • 44. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
    Mohammed S, Nour I, Shabaan AE, Shouman B, Abdel-Hady H, Nasef N.
    Eur J Pediatr; 2015 Jul 31; 174(7):949-56. PubMed ID: 25644724
    [Abstract] [Full Text] [Related]

  • 45. Comparative evaluation of caffeine and theophylline for weaning premature infants from the ventilator.
    Sims ME, Rangasamy R, Lee S, Chung H, Cohen J, Walther FJ.
    Am J Perinatol; 1989 Jan 31; 6(1):72-5. PubMed ID: 2642707
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Methylxanthine treatment for apnea in preterm infants.
    Henderson-Smart DJ, Steer P.
    Cochrane Database Syst Rev; 2001 Jan 31; (3):CD000140. PubMed ID: 11686952
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [A comparative study about the therapeutic effect of theophylline and doxapram in apnoeic disorders].
    Möller JC, Austing A, Püst B, Kohl M, Reiss I, Iven H, Gortner L.
    Klin Padiatr; 1999 Jan 31; 211(2):86-91. PubMed ID: 10407818
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. On the caffeination of prematurity.
    Stevenson DK.
    N Engl J Med; 2007 Nov 08; 357(19):1967-8. PubMed ID: 17989390
    [No Abstract] [Full Text] [Related]

  • 53. Caffeine for apnea of prematurity: a neonatal success story.
    Kreutzer K, Bassler D.
    Neonatology; 2014 Nov 08; 105(4):332-6. PubMed ID: 24931325
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits and risks at age 5 years in the international Caffeine for Apnea of Prematurity (CAP) trial.
    Schmidt B.
    Biol Neonate; 2005 Nov 08; 88(3):208-13. PubMed ID: 16210843
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Aminophylline versus caffeine citrate for apnea and bradycardia prophylaxis in premature neonates.
    Larsen PB, Brendstrup L, Skov L, Flachs H.
    Acta Paediatr; 1995 Apr 08; 84(4):360-4. PubMed ID: 7795341
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.